Pulmonx Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:LUNG Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Sep 25	SellUS$15,630	David Lehman	Individual	9,769	US$1.60
02 Sep 25	SellUS$10,469	Geoffrey Rose	Individual	6,543	US$1.60
02 Sep 25	SellUS$12,698	Mehul Joshi	Individual	7,936	US$1.60
02 Sep 25	SellUS$15,437	Steven Williamson	Individual	9,648	US$1.60
12 Jun 25	SellUS$25,280	Richard Ferrari	Individual	8,000	US$3.16
05 Jun 25	BuyUS$71,362	Daniel Florin	Individual	23,321	US$3.06
02 Jun 25	SellUS$32,736	David Lehman	Individual	10,457	US$3.14
02 Jun 25	SellUS$21,748	Geoffrey Rose	Individual	6,947	US$3.14
02 Jun 25	SellUS$25,231	Mehul Joshi	Individual	8,061	US$3.13
02 Jun 25	SellUS$31,059	Steven Williamson	Individual	9,923	US$3.13
03 Mar 25	SellUS$41,193	Geoffrey Rose	Individual	5,779	US$7.14
03 Mar 25	SellUS$62,354	David Lehman	Individual	8,733	US$7.14
03 Mar 25	SellUS$197,699	Steven Williamson	Individual	27,689	US$7.14
03 Mar 25	SellUS$102,414	Mehul Joshi	Individual	14,384	US$7.12
02 Dec 24	SellUS$34,006	David Lehman	Individual	5,497	US$6.19
02 Dec 24	SellUS$27,065	Geoffrey Rose	Individual	4,376	US$6.19

Insider Trading Volume

Insider Buying: LUNG insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of LUNG?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,082,886	2.66%
General Public	5,462,406	13.4%
Institutions	34,201,264	83.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 72.55% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.7%	PRIMECAP Management Company	5,164,681	US$8.7m	-4.62%	0.01%
8.34%	Morgan Stanley	3,399,056	US$5.7m	0.25%	no data
6.6%	BlackRock, Inc.	2,690,798	US$4.5m	-3.46%	no data
5.63%	The Vanguard Group, Inc.	2,293,988	US$3.9m	0.51%	no data
5.3%	FMR LLC	2,160,483	US$3.7m	-49.3%	no data
4.64%	Deerfield Management Company, L.P.	1,890,000	US$3.2m	0%	0.05%
2.87%	BNPP Asset Management Holding	1,168,513	US$2.0m	-6.66%	no data
2.86%	Millennium Management LLC	1,166,527	US$2.0m	460%	no data
2.76%	Deutsche Asset & Wealth Management	1,125,861	US$1.9m	-1.85%	no data
2.28%	Silvercrest Asset Management Group LLC	930,557	US$1.6m	0%	0.01%
2.28%	Geode Capital Management, LLC	929,397	US$1.6m	0.2%	no data
1.95%	State Street Global Advisors, Inc.	794,185	US$1.3m	4.4%	no data
1.85%	Braidwell LP	752,541	US$1.3m	0%	0.05%
1.6%	Rock Springs Capital Management LP	651,100	US$1.1m	29.3%	0.06%
1.48%	Parkman Healthcare Partners LLC	605,029	US$1.0m	-1.12%	0.1%
1.2%	D. E. Shaw & Co., L.P.	489,880	US$827.9k	0.68%	no data
1.18%	Bank of America Corporation	481,121	US$813.1k	558%	no data
1.12%	Dimensional Fund Advisors LP	455,344	US$769.5k	14.6%	no data
1.1%	JP Morgan Asset Management	449,195	US$759.1k	-7.72%	no data
1.04%	GSA Capital Partners LLP	423,725	US$716.1k	0%	0.05%
0.87%	Northern Trust Global Investments	355,598	US$601.0k	-2.55%	no data
0.77%	Charles Schwab Investment Management, Inc.	313,738	US$530.2k	-2.25%	no data
0.76%	Schonfeld Strategic Advisors LLC	309,651	US$523.3k	11%	no data
0.7%	Jefferies Financial Group Inc.	285,110	US$481.8k	0%	0.01%
0.68%	UBS Asset Management AG	275,895	US$466.3k	232%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/03 11:12
End of Day Share Price	2025/10/03 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pulmonx Corporation is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Travis Steed	BofA Global Research
William Plovanic	Canaccord Genuity
John Young	Canaccord Genuity